In a randomized clinical trial, researchers found risk-based breast cancer screening was as safe as annual screening for detecting advanced cancers but did not reduce breast biopsy rates.

BOOG 13-08 shows skipping sentinel lymph node biopsy in patients 50+ with early-stage, hormone receptor–positive, ...

A mum-of-two was diagnosed with breast cancer after she had a gut instinct to squeeze her left breast in the shower and felt ...

A comprehensive study by the Chennai Breast Centre, a renowned one-stop breast cancer facility, revealed that a significant ...

SAN ANTONIO -- Many patients with early breast cancer can safely skip sentinel lymph node biopsy (SLNB), results of a large ...

Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor limbic encephalitis is a rare neurological disorder often associated with malignancies. We present the case of a patient in ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, ...

Liquid biopsy using ctDNA refines risk stratification for patients with residual cancer burden post-neoadjuvant therapy, ...

A study reveals that integrated breast cancer assessment centres can reduce misdiagnoses and improve timely diagnoses in ...

The Santa Ynez Band of Chumash Indians recently presented a check for $10,083 to the Breast Imaging Center at Goleta ...

Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunes ...

Bang Bang” singer Jessie J, 37, has been center stage this year not just for her performances, but because she’s sharing her ...